- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens resumes oncology shipments
The Oncology Care Systems division of Siemens Medical Systemshas received Food and Drug Administration clearance to resumeshipping and manufacturing in the U.S., the vendor reported lastweek. Siemens halted domestic shipments from the Concord,
The Oncology Care Systems division of Siemens Medical Systemshas received Food and Drug Administration clearance to resumeshipping and manufacturing in the U.S., the vendor reported lastweek. Siemens halted domestic shipments from the Concord, CA,facility last year after FDA audits uncovered problems in manufacturingprocesses at the plant (SCAN 10/12/94).
Siemens received FDA approval on Nov. 2 to resume U.S. shipping,and got the agency's go-ahead in October to manufacture for U.S.customers. The facility has been shipping and manufacturing forinternational customers since March, the company reported. Theplant makes radiation oncology treatment and verification products.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
